GALDERMA GROUP AG (GALDY) Balance Sheet

NYSE: GALDYAssets, liabilities, debt and equity over 3 years.

GALDY balance sheet, 2025

December 31, 2025 · U.S. dollars

$13.39B assets = $5.24B liabilities + $8.15B equity

What it owns$13.39BCash & ST investments: $780.0M (5.8%)$780.0MReceivables: $893.0M (6.7%)Receivables $893.0MInventory: $525.0M (3.9%)Other current: $239.0M (1.8%)PP&E: $744.0M (5.6%)Goodwill & intangibles: $9.77B (72.9%)Goodwill & intangibles$9.77B · 73%Other non-current: $444.0M (3.3%)=How it is financed$13.39BCurrent liabilities: $2.06B (15.3%)Current liabilities$2.06B · 15%Long-term debt: $2.58B (19.3%)Long-term debt$2.58B · 19%Other LT liabilities: $610.0M (4.6%)Shareholders’ equity: $8.15B (60.8%)Shareholders’ equity$8.15B · 61%

Both columns are drawn to the same scale: what GALDY owns equals what it owes plus shareholders’ equity. Hover a block for its value.

GALDY financial health

Current ratio1.19
Adequate · current assets cover current liabilities 1.19×
Debt / equity0.32
Low leverage · $0.32 of debt for each $1 of equity
Equity / assets60.8%
Equity-funded · of assets funded by shareholders
Cash / debt30.2%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles72.9%
Mostly intangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

GALDY balance sheet trends, 2023–2025

GALDERMA GROUP AG balance sheet trends
MetricTrendThenLatestChange
Total assets$12.47B2023$13.39B2025+3.6%/yr
Total liabilities$7.10B2023$5.24B2025−14.1%/yr
Shareholders’ equity$5.37B2023$8.15B2025+23.2%/yr
Cash & short-term investments$368.0M2023$780.0M2025+45.6%/yr
Total debt$4.75B2023$2.58B2025−26.3%/yr
Net cash (debt)−$4.38B2023−$1.80B2025+$2.6B
Working capital$45.0M2023$382.0M2025+$337.0M
Book value per share$22.602023$34.742025+24.0%/yr
Current ratio1.0320231.192025+0.16
Debt / equity0.8820230.322025−0.57
Shares outstanding237.6M2023234.6M2025−0.6%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

GALDY assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

GALDY liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

GALDY debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

GALDY balance sheet

GALDERMA GROUP AG annual balance sheet
202520242023
Assets
Cash & short-term investments$780.0M$457.0M$368.0M
Cash & equivalents$780.0M$457.0M$368.0M
Receivables$893.0M$754.0M$631.0M
Inventory$525.0M$403.0M$420.0M
Other current assets$239.0M$229.0M$197.0M
Total current assets$2.44B$1.84B$1.62B
Property, plant & equipment (net)$744.0M$578.0M$530.0M
Goodwill & intangible assets$9.77B$9.96B$10.05B
Long-term investments$0$0$0
Other non-current assets$444.0M$239.0M$274.0M
Total assets$13.39B$12.62B$12.47B
Liabilities
Accounts payable$800.0M$571.0M$557.0M
Total current liabilities$2.06B$1.53B$1.57B
Long-term debt$2.58B$2.64B$4.75B
Lease obligations$148.0M$117.0M$122.0M
Other long-term liabilities$610.0M$662.0M$783.0M
Total liabilities$5.24B$4.83B$7.10B
Shareholders' equity
Retained earnings (deficit)$6.35B$5.68B−$901.0M
Total shareholders' equity$8.15B$7.79B$5.37B
Key figures
Total debt$2.58B$2.64B$4.75B
Net cash (debt)−$1.80B−$2.18B−$4.38B
Working capital$382.0M$315.0M$45.0M
Tangible book value−$1.62B−$2.17B−$4.68B
Book value per share$34.74$32.81$22.60
Shares outstanding234.6M237.4M237.6M
Current ratio1.191.211.03
Quick ratio0.810.790.64
Debt / equity0.320.340.88
Equity / assets60.8%61.7%43.1%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed —); data from EODHD.

GALDY financial position

At the end of fiscal 2025 (December 31, 2025), GALDERMA GROUP had total assets of $13.4 billion (up 6.2% from a year earlier), total liabilities of $5.2 billion and shareholders' equity of $8.1 billion. It held $780.0 million in cash and short-term investments against $2.6 billion of debt, net debt of $1.8 billion. Its current ratio was 1.19.

Related: GALDY income statement, GALDY cash flow statement, GALDY key metrics. See the GALDY stock overview for the latest quote and news.

GALDY balance sheet FAQ

What are GALDERMA GROUP's total assets?

GALDERMA GROUP reported total assets of $13.4 billion at the end of fiscal 2025 (December 31, 2025), compared with $12.6 billion a year earlier.

How much debt does GALDERMA GROUP have?

GALDERMA GROUP had $2.6 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.32.

How much cash does GALDERMA GROUP have?

GALDERMA GROUP held $780.0 million in cash and short-term investments at the end of fiscal 2025; with $2.6 billion of debt that is net debt of $1.8 billion.

What is GALDERMA GROUP's book value?

GALDERMA GROUP's shareholders' equity (book value) was $8.1 billion at the end of fiscal 2025, or $34.74 per share.

What is GALDERMA GROUP's current ratio?

GALDERMA GROUP had current assets of $2.4 billion and current liabilities of $2.1 billion, a current ratio of 1.19 (it can cover its short-term obligations).

How much goodwill does GALDERMA GROUP have?

GALDERMA GROUP carried $9.8 billion of goodwill and intangible assets, 72.9% of total assets, at the end of fiscal 2025.

Drug Manufacturers - Specialty & Generic: balance sheet